Getty Realty (NYSE:GTY) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsBrian Dickman - CFOChristopher Constant - CEOJana Galan - DirectorJoshua Dicker - EVP, General Counsel, and SecretaryMark Olear - CIO and COOMitch Germain - Managing DirectorRJ Ryan - SVP of AcquisitionsConference Call ParticipantsAlex Fijan - AnalystUpal Rana - Senior Equity Research AnalystNone - AnalystOperatorGood morning, and welcome to the Getty Realty fourth quarter 2025 earnings call. This call is being r ...

PHINIA (NYSE:PHIN) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsBrady Ericson - CEOChris Gropp - CFOKellen Ferris - VP of Investor RelationsConference Call ParticipantsBobby Brooks - AnalystDrew Estes - AnalystJake Scholl - AnalystJoe Spak - AnalystOperatorGood morning, and welcome everyone to the PHINIA fourth quarter 2025 earnings call. Today's conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there wil ...

Rollins (NYSE:ROL) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsBrian McNamara - Managing DirectorGreg Parrish - Vice President of Equity ResearchJason Haas - DirectorJerry Gahlhoff - President and CEOKen Krause - EVP and CFOLyndsey Burton - VP of Investor RelationsPeter Keith - Managing DirectorConference Call ParticipantsAshish Sabadra - Managing Director and Senior Equity AnalystGeorge Tong - Senior Research AnalystJosh Chan - Equity Research AnalystManav Patnaik - Equity Resea ...

LXP Industrial Trust (NYSE:LXP) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsBrendan Mullinix - CIOHeather Gentry - VP of Investor RelationsJames Dudley - EVP and Director of Asset ManagementNathan Brunner - CFONikita Bely - Senior DirectorWill Eglin - Chairman and CEOConference Call ParticipantsJames Kammert - Managing Director and Senior REIT AnalystTodd Thomas - Equity Research AnalystVince Tibone - Senior AnalystOperatorThank you for standing by. My name is Rebecca, and I will ...

Financial Data and Key Metrics Changes - As of the end of Q4 2025, fee-paying assets under management (AUM) reached $29.4 billion, reflecting a 15% year-over-year increase [19] - Fee-related revenues (FRR) for 2025 were $297.3 million, a 13% increase from 2024, excluding direct and secondary catch-up fees [22] - Adjusted net income (ANI) for Q4 was $30.2 million, a 14% decrease from the previous year, primarily due to high catch-up fee revenue in Q4 2024 [26] Business Line Data and Key Metrics Changes - The company raised and deployed a record $5.1 billion in organic gross new fee-paying AUM in 2025, exceeding initial guidance by over $1 billion [11] - Private equity strategies raised and deployed $325 million, venture capital solutions raised and deployed $178 million, and private credit strategies added $338 million to fee-paying AUM in Q4 [24] - The average core fee rate was 109 basis points in Q4 and 104 basis points for 2025, with expectations of 103 basis points for 2026 [23] Market Data and Key Metrics Changes - The company has expanded its product set to meet investor demand for private markets, including launching its first evergreen product and a fund directed at European investors [13] - The acquisition of Qualitas Funds established the company's presence outside the U.S., complemented by the opening of a new office in Dubai [14] Company Strategy and Development Direction - The company aims to double fee-paying AUM to $50 billion by the end of 2029, primarily through organic growth [15] - The strategic acquisition of Stellus is expected to enhance direct lending capabilities and align with the company's focus on the middle and lower middle market [9] - The company is committed to returning capital to shareholders, having repurchased nearly 11 million shares since the beginning of 2024 [27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory and the potential for further expansion in the middle and lower middle market [18] - The company anticipates strong fundraising in 2026 and 2027, targeting at least $10 billion in gross fee-paying AUM [16] - Management highlighted the importance of strong fund performance and product innovation to sustain growth [12] Other Important Information - The company appointed two new independent directors to enhance governance and broaden its brand reach [14] - Operating expenses decreased in 2025 to $231.8 million from $235.8 million in 2024, reflecting adjustments related to prior acquisitions [25] Q&A Session Summary Question: AI's impact on private markets - Management noted a meaningful exposure to AI through its venture portfolio, with investments performing well, while maintaining modest exposure to SaaS and software [30][31] Question: Private markets wealth strategy - Management clarified that while private wealth was not a primary focus, they are leveraging existing products and partnerships, such as with CAIS, to enhance distribution in the private wealth channel [33][37] Question: Details on Stellus acquisition - Management indicated that Stellus's acquisition would be modestly accretive and that more detailed guidance would be provided closer to the closing date [41][42] Question: Stellus's sourcing funnel and growth acceleration - Management emphasized the strong fit between Stellus and the company's existing sponsor ecosystem, with plans to enhance sourcing and accelerate growth post-acquisition [49][52] Question: Capital management and M&A strategy - Management stated intentions to balance stock buybacks with debt reduction post-acquisition, while remaining focused on strategic M&A opportunities in private credit and real assets [55][58]

Cognex (NasdaqGS:CGNX) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsBrooke Flynn - Equity Research AssociateDennis Fehr - CFOGreer Aviv - Head of Investor RelationsMatt Moschner - CEOConference Call ParticipantsGuy Hardwick - Equity Research AnalystJairam Nathan - Equity Research AnalystJamie Cook - Managing Director and Senior Equity Research AnalystJoe Ritchie - Managing Director and Senior Equity Research AnalystKen Newman - VP and Equity Research AnalystMichael Feniger - VP an ...

TripAdvisor (NasdaqGS:TRIP) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsAngela White - VP of Investor RelationsMatt Goldberg - President and CEOMichael Noonan - CFONaved Khan - Managing Director in Equity ResearchConference Call ParticipantsEric Sheridan - Senior Equity Research AnalystsJed Kelly - Managing Director and Senior AnalystLloyd Walmsley - Managing Director and Senior Equity Research AnalystNafeesa Gupta - VP and Equity Research AnalystStephen Ju - Managing Director an ...

Rezolve AI (NasdaqGM:RZLV) M&A announcement February 12, 2026 08:30 AM ET Company ParticipantsDan Wagner - CEOJamie Samaha - CEOMichael Guido - VP of Investor RelationsRohit Kulkarni - Managing DirectorConference Call ParticipantsBrian Kinstlinger - Senior Technology AnalystMatt VanVleet - Equity Research AnalystMike Latimore - Managing Director and Equity AnalystScott Buck - Senior Research AnalystThomas Forte - Senior Research AnalystOperatorGood day, and thank you for standing by. Welcome to Rezolve AI B ...

Cognex (NasdaqGS:CGNX) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsBrooke Flynn - Equity Research AssociateDennis Fehr - CFOGreer Aviv - Head of Investor RelationsGuy Hardwick - DirectorMatt Moschner - CEOConference Call ParticipantsJamie Cook - Managing Director and Senior Equity Research AnalystJerome Nathan - Equity Research AnalystJoe Ritchie - Managing Director and Senior Equity Research AnalystKen Newman - VP and Equity Research AnalystMichael Feniger - VP and Equity Resear ...

Baxter International (NYSE:BAX) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsAndrew Hider - President and CEODavid Roman - Managing DirectorJoanne Wuensch - Managing Director in the Equity Research DivisionJoel Grade - EVP and CFOKevin Moran - VP and Head of Investor RelationsVijay Kumar - Senior Managing DirectorConference Call ParticipantsDanielle Antalffy - Senior Equity Research AnalystLarry Biegelsen - Managing Director and Senior Medical Device Equity Research AnalystRobbie ...